Henrich Jill

Track

Insider profile

Performance

Overall performance
4.1
Performance over holding periods
4.1
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Henrich Jill's trades of Atara Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-05 2025-03-03
PlS Planned sale
93,914 +22.9%
58.99
US$4,897,599 		93,914 +22.9% 58.99 US$4,897,599
2025-03-03 2025-03-03
PrS Proposed sale
11,116
261.66
US$1,213,874 		11,116 261.66 US$1,213,874
2024-11-20 2024-11-18
S Sale
25,927 -29.0%
198.81
US$209,633 		25,927 -29.0% 198.81 US$209,633
2024-11-18 2024-11-18
PrS Proposed sale
1,112
12.00
US$13,344 		1,112 12.00 US$13,344
2024-08-20 2024-08-16
S Sale
132 -0.6%
6.63
US$875 		132 -0.6% 6.63 US$875
2024-08-20 2024-08-16
PlS Planned sale
831 -3.9%
6.63
US$5,509 		831 -3.9% 6.63 US$5,509
2024-08-16 2024-08-16
PrS Proposed sale
1,113
8.02
US$8,926 		1,113 8.02 US$8,926
2024-05-20 2024-05-16
S Sale
25,750 -4.6%
0.62
US$15,888 		25,750 -4.6% 0.62 US$15,888
2024-05-16 2024-05-16
PrS Proposed sale
27,754
0.64
US$17,762 		27,754 0.64 US$17,762
2024-03-06 2024-03-04
S Sale
3,879 -0.7%
0.72
US$2,793 		3,879 -0.7% 0.72 US$2,793
2024-03-04 2024-03-04
PrS Proposed sale
3,865
0.77
US$2,979 		3,865 0.77 US$2,979
2023-11-20 2023-11-16
S Sale
3,267 -3.0%
0.39
US$1,271 		3,267 -3.0% 0.39 US$1,271
2023-08-18 2023-08-16
S Sale
558 -0.5%
1.65
US$923 		558 -0.5% 1.65 US$923
2023-08-18 2023-08-16
S Sale
2,788 -2.5%
1.65
US$4,609 		2,788 -2.5% 1.65 US$4,609